Xenetic Biosciences, Inc.
XBIONasdaqCIK 1534525HealthcareFiscal year ends Dec 31
Reports and events: 251 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2317:20 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-26-007340 |
| 2026-09-1607:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-26-007181 |
| 2026-08-0708:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-26-006077 |
| 2026-08-0616:30 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001683168-26-006061 |
| 2026-05-1308:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-26-003766 |
| 2026-05-1216:30 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001683168-26-003727 |
| 2026-04-2417:15 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001683168-26-003207 |
| 2026-04-2417:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001683168-26-003203 |
| 2026-03-1308:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-26-001744 |
| 2026-03-1217:00 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001683168-26-001737 |
| 2026-01-0917:00 ET | 8-K | 8.01 Other events | 0001683168-26-000196 |
| 2025-12-1117:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-25-009076 |
| 2025-11-1308:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-25-008288 |
| 2025-11-1216:30 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001683168-25-008259 |
| 2025-10-3116:10 ET | DEF 14A | Proxy statementPeriod 2025-12-11 | 0001683168-25-007872 |
| 2025-10-1408:48 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-25-007528 |
| 2025-08-1308:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-25-006001 |
| 2025-08-1217:00 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001683168-25-005983 |
| 2025-05-1408:27 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-25-003513 |
| 2025-05-1317:00 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001683168-25-003496 |
| 2025-05-1316:30 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001683168-25-003493 |
| 2025-04-2917:00 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001683168-25-002939 |
| 2025-04-1008:00 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001683168-25-002396 |
| 2025-03-1913:15 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001683168-25-001712 |
| 2025-03-1908:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-25-001693 |
| 2025-03-1816:30 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001683168-25-001686 |
| 2024-12-1316:30 ET | 8-K | 5.07 Shareholder vote results | 0001683168-24-008712 |
| 2024-11-1308:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-24-007929 |
| 2024-11-1216:30 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001683168-24-007903 |
| 2024-11-0709:00 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-24-007710 |
| 2024-10-3117:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001683168-24-007527 |
| 2024-10-3116:30 ET | DEF 14A | Proxy statementPeriod 2024-12-11 | 0001683168-24-007517 |
| 2024-08-1408:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-24-005600 |
| 2024-08-1316:32 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001683168-24-005572 |
| 2024-06-2116:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001683168-24-004415 |
| 2024-05-2217:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-24-003779 |
| 2024-05-1008:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-24-003192 |
| 2024-05-0917:00 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001683168-24-003172 |
| 2024-04-2616:30 ET | 10-K/A | Annual report, amendedPeriod 2023-12-31 | 0001683168-24-002740 |
| 2024-03-2208:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-24-001606 |
| 2024-03-2117:00 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001683168-24-001594 |
| 2024-03-1813:45 ET | SC 13D/A | Ownership report, active investor, amended | 0001213900-24-023384 |
| 2024-02-1209:15 ET | 8-K | 7.01 Regulation FD disclosure | 0001683168-24-000866 |
| 2023-12-0817:00 ET | 8-K | 5.07 Shareholder vote results | 0001683168-23-008731 |
| 2023-11-1317:00 ET | DEF 14A | Proxy statementPeriod 2023-12-06 | 0001683168-23-007992 |
| 2023-11-1308:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-23-007922 |
| 2023-11-0917:00 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001683168-23-007820 |
| 2023-09-1812:21 ET | SC 13D/A | Ownership report, active investor, amended | 0001213900-23-077250 |
| 2023-08-1108:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-23-005538 |
| 2023-08-1016:30 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001683168-23-005513 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:13 ET. Listed shows no prices and gives no investment advice.